Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months

被引:25
作者
Ziesenitz, Victoria C. [1 ,2 ]
Zutter, Andreas [3 ]
Erb, Thomas O. [3 ]
van den Anker, Johannes N. [1 ,4 ]
机构
[1] Univ Basel, Childrens Hosp, Div Paediat Pharmacol & Pharmacometr, Spitalstr 33, CH-4056 Basel, Switzerland
[2] Univ Childrens Hosp, Dept Paediat Cardiol, Heidelberg, Germany
[3] Univ Basel, Div Paediat Anaesthesiol, Childrens Hosp, Basel, Switzerland
[4] Childrens Natl Hlth Syst, Div Clin Pharmacol, Washington, DC USA
基金
美国国家卫生研究院;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PATENT DUCTUS-ARTERIOSUS; POSTOPERATIVE PAIN; ADVERSE-REACTIONS; ACETAMINOPHEN; PHARMACOKINETICS; CHILDREN; PARACETAMOL; DISPOSITION; ASTHMA;
D O I
10.1007/s40272-017-0235-3
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Ibuprofen is a non-steroidal anti-inflammatory drug frequently administered to children of various ages for relief of fever and pain and is approved as an over-the-counter medication in many countries worldwide. Although there are extensive data on its efficacy and safety in children and adults, there are divergent dosing recommendations for analgesia and treatment of fever in infants, especially in the age group between 3 and 6 months of age. In this article, we have assessed the safety and efficacy of ibuprofen use in infants in an attempt to find the optimal method of pain and fever management in this specific age group. Based on the current evidence, short-term use of ibuprofen is considered safe in infants older than 3 months of age having a body weight above 5-6 kg when special attention is given to the hydration of the patient. Ibuprofen should be prescribed based on body weight using a dose of 5-10 mg/kg. This dose can be administered 3-4 times a day resulting in a maximum total daily dose of 30-40 mg/kg. The rectal route has been shown to be less reliable because of erratic absorption, especially in young infants. Since most efficacy and safety data have been derived from trials in infants with fever, future studies should focus on the efficacy of ibuprofen in young infants with pain.
引用
收藏
页码:277 / 290
页数:14
相关论文
共 74 条
  • [1] [Anonymous], 2015, 22348 NDA S005
  • [2] [Anonymous], 2011, FACH PECFENT NAS
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] [Anonymous], 2003, 573CHC9127001
  • [5] Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant
    Aranda, JV
    Varvarigou, A
    Beharry, K
    Bansal, R
    Bardin, C
    Modanlou, H
    Papageorgiou, A
    Chemtob, S
    [J]. ACTA PAEDIATRICA, 1997, 86 (03) : 289 - 293
  • [6] Safety profile of ibuprofen suspension in young children
    Ashraf E.
    Ford L.
    Geetha R.
    Cooper S.
    [J]. InflammoPharmacology, 1999, 7 (3) : 219 - 225
  • [7] Ibuprofen versus paracetamol in pediatric fever: objective and subjective randomized, blindings from a linded study
    Autret-Leca, Elisabeth
    Gibb, Iain A.
    Goulder, Michael A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) : 2205 - 2211
  • [8] Drug use and upper gastrointestinal complications in children: a case-control study
    Bianciotto, Manuela
    Chiappini, Elena
    Raffaldi, Irene
    Gabiano, Clara
    Tovo, Pier-Angelo
    Sollai, Sara
    de Martino, Maurizio
    Mannelli, Francesco
    Tipo, Vincenzo
    Da Cas, Roberto
    Traversa, Giuseppe
    Menniti-Ippolito, Francesca
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (03) : 218 - 221
  • [9] SINGLE-DOSE PHARMACOKINETICS OF IBUPROFEN AND ACETAMINOPHEN IN FEBRILE CHILDREN
    BROWN, RD
    WILSON, JT
    KEARNS, GL
    EICHLER, VF
    JOHNSON, VA
    BERTRAND, KM
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (03) : 231 - 241
  • [10] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817